Promoting the recovery of water through innovative treatment and desalination systems within water-intensive energy production processes: Three case studies

L'abstract è presente nell'allegato / the abstract is in the attachmen

Desalination of brackish groundwater and reuse of wastewater by forward osmosis coupled with nanofiltration for draw solution recovery

Abstract This study evaluates a treatment system centered on forward osmosis (FO) to extract high-quality water from real brackish groundwater and wastewater. The groundwater had salinity of 4 g/L, while the wastewater sample consisted of a secondary effluent. These feed solutions were treated first in a FO step, achieving a recovery of >60%. Subsequently, the diluted draw solutions were subject to a nanofiltration (NF) step to regenerate their original osmotic pressure and to simultaneously collect a final permeate product. Magnesium chloride and sodium sulfate were both suitable draw solutes for this application. MgCl2 had a larger specific reverse salt flux and induced a more pronounced fouling-related flux decline with groundwater samples. Na2SO4 was re-concentrated with a higher permeability NF membrane but may require the use of anti-scalants. The average fluxes obtained in high-recovery batch FO were between 5 and 11 L m−2h−1 with an initial bulk draw osmotic pressure in the range of 12–15 bar. Relatively low flux decline was observed in fouling experiments with both samples, while physical cleaning proved promising to recover the related loss in productivity. The final product waters were all of very high quality, suggesting the potential of this coupled system for water reuse and desalination. Some challenges related to the relatively low water flux in the FO step, as well as the loss of draw solutes and the gradual change in composition of the draw solution, need further analysis to establish the technical and economic feasibility of the system

Process optimization of osmotic membrane distillation for the extraction of valuable resources from water streams

The rising demand for sustainable wastewater management and high-value resource recovery is pressing industries involved in, e.g., textiles, metals, and food production, to adopt energy-efficient and flexible liquid separation methods. The current techniques often fall short in achieving zero liquid discharge and enhancing socio-economic growth sustainably. Osmotic membrane distillation (OMD) has emerged as a low-temperature separation process designed to concentrate valuable elements and substances in dilute feed streams. The efficacy of OMD hinges on the solvent’s migration from the feed to the draw stream through a hydrophobic membrane, driven by the vapor pressure difference induced by both temperature and concentration gradients. However, the intricate interplay of heat and mass processes steering this mechanism is not yet fully comprehended or accurately modeled. In this research, we conducted a combined theoretical and experimental study to explore the capabilities and thermodynamic limitations of OMD. Under diverse operating conditions, the experimental campaign aimed to corroborate our theoretical assertions. We derived a novel equation to govern water flux based on foundational principles and introduced a streamlined version for more straightforward application. Our findings spotlight complex transport-limiting and self-adjusting mechanisms linked with temperature and concentration polarization phenomena. Compared with traditional methods like membrane distillation and osmotic dilution, which are driven by solely temperature or concentration gradients, OMD may provide improved and flexible performance in target applications. For instance, we show that OMD—if properly optimized—can achieve water vapor fluxes 50% higher than osmotic dilution. Notably, OMD operation at reduced feed temperatures can lead to energy savings ranging between 5 and 95%, owing to the use of highly concentrated draw solutions. This study underscores the potential of OMD in real-world applications, such as concentrating lithium in wastewater streams. By enhancing our fundamental understanding of OMD’s potential and constraints, we aim to broaden its adoption as a pivotal liquid separation tool, with focus on sustainable resource recovery

Microalgae biomass concentration and reuse of water as new cultivation medium using ceramic membrane filtration

The aim of this study is to advance means for microalgae dewatering with the simultaneous reuse of water as new cultivation medium, specifically through ceramic membrane filtration. Three algae, namely, Spirulina platensis, Scenedesmus obliquus, and Chlorella sorokiniana were tested by filtering suspensions with four ceramic membranes having nominal pore sizes of 0.8 μm, 0.14 μm, 300 kDa, 15 kDa. The observed flux values and organic matter removal rates were related to the membrane pore size and cake layer properties, with some differences in productivity between algae types, likely due to cell size and shape. Interestingly, similar near steady-state fluxes (70-120 L m-2h-1) were measured using membranes with nominal pore size above 15 kDa, suggesting the dominance of cake layer filtration independently of the initial flux. Virtually complete algae cells rejections and high nutrient passage (>75%) were observed in all combinations. When the permeate streams were used as media for new growth cycles of the various algae, no or little growth was observed with Spirulina p., while Chlorella s. (permeate from 300 kDa membrane) and especially Scenedesmus o. (permeate from 0.14 μm membrane) showed the fastest growth rates, almost comparable to those observed with ideal fresh media

Concentration of phycocyanin and coffee extracts in aqueous solutions with osmotically-assisted membrane distillation

Osmotic membrane distillation (OMD) is a dewatering process that exploits combined temperature and osmotic pressure gradients to drive water vapor fluxes under mild operation conditions. In this study, the feasibility of OMD is evaluated for the concentration of phycocyanin and coffee extract solutions, with the goal to safeguard the quality of the extracts. Different feed solution temperatures were studied, namely, 35 °C, 45 °C, 55 °C, while keeping a concentration of 4 M CaCl2 in the extraction solution. The target concentration factor was set to 4, equivalent to a water recovery rate of 75 %. The results suggest that a temperature equal to or below 45 °C should be chosen for the concentration of phycocyanin to prevent degradation and to minimize fouling, while higher temperatures may be used for the recovery of the coffee extract. The combined gradients provided water fluxes around or above 4 L m−2h−1 with both extracts under relatively mild conditions, even at high concentration factors. Qualitative membrane fouling inspection was corroborated by estimating the fraction of productivity lost due to fouling, which was larger for higher feed temperatures and for the phycocyanin extracts, and had values between roughly 20 and 70 %. Results also suggest that the quality of the extracts was maintained, based on the measured purity and content of the target compounds in the concentrated solutions. Specifically, no trace of extraneous compounds was found, and no salt passage was observed from the extraction solution to the feed solution, suggesting that OMD has the potential to concentrate sensitive components

Modeling and experimental evaluation of membrane distillation aimed at urine treatment for direct potable reuse in space stations

Improving wastewater reuse systems represents a game changer for the economy of space exploration activities. The goal of this research is to evaluate direct contact membrane distillation for the treatment of urine aimed at direct potable reuse in space stations. A transient, 2-D model able to predict the membrane distillation system behavior under different operating conditions is developed. The model is validated by experimental tests conducted with a synthetic urine-like feed solution, considering both productivity and final water quality. The water flux and quality analyses imply high rejection of soluble salts and organics. However, direct water reuse may be compromised by the ammonia passage. A sensitivity analysis is thus performed to investigate the effects of feed pH, temperature, and cross-flow velocity on water flux and ammonia passage. The system shows the capability of treating 8 L of urine up to 90–95 % recovery rate, during 10 h of daily operation at 40 °C feed and 20 °C distillate inlet temperatures. This amount is sufficient to satisfy four crew members while meeting high system compactness. Concurrently, the ammonia passage may be limited by lowering the feed pH, thus easing the post-treatment steps necessary for safe direct reuse

Critical role of maternal selenium nutrition in neurodevelopment: Effects on offspring behavior and neuroinflammatory profile

Research in both animals and humans shows that some nutrients are important in pregnancy and during the first years of life to support brain and cognitive development. Our aim was to evaluate the role of selenium (Se) in supporting brain and behavioral plasticity and maturation. Pregnant and lactating female rats and their offspring up to postnatal day 40 were fed isocaloric diets differing in Se content - i.e., Optimal, SubOptimal, and Deficient - and neurodevelopmental, neu-roinflammatory, and anti-oxidant markers were analyzed. We observed early adverse behavioral changes in juvenile rats only in SubOptimal offspring. In addition, SubOptimal, more than Deficient supply reduced basal glial reactivity in sex dimorphic and brain-area specific fashion. In female offspring, Deficient and SubOptimal diets reduced the antioxidant Glutathione peroxidase (GPx) activity in the cortex and in the liver, the latter being the key organ regulating Se metabo-lism and homeostasis. The finding that Se SubOptimal was more detrimental than Se Deficient diet may suggest that maternal Se Deficient diet, leading to a lower Se supply at earlier stages of fetal development, stimulated homeostatic mechanisms in the offspring that were not initiated by SubOptimal Se. Our observations demonstrate that even moderate Se deficiency during early life negatively may affect, in a sex-specific manner, optimal brain development

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

Background: Drug survival, defined as the length of time from initiation to discontinuation of a given therapy, allows comparisons between drugs, helps to predict patient's likelihood of remaining on a specific treatment, and achieving the best decision for each patient in daily clinical practice. Objective: The aim of this study was to provide data on drug survival of secukinumab, ixekizumab, brodalumab, guselkumab, tildrakizumab, and risankizumab in a large international cohort, and to identify clinical predictors that might have an impact on the drug survival of these drugs. Methods: This was a retrospective, multicentric, multi-country study that provides data of adult patients with moderate to severe psoriasis who started treatment with an interleukin (IL)-17 or IL-23 inhibitor between 1 February 2015 and 31 October 2021. Data were collected from 19 distinct hospital and non-hospital-based dermatology centers from Canada, Czech Republic, Italy, Greece, Portugal, Spain, and Switzerland. Kaplan-Meier estimator and proportional hazard Cox regression models were used for drug survival analysis. Results: A total of 4866 treatment courses (4178 patients)-overall time of exposure of 9500 patient-years-were included in this study, with 3164 corresponding to an IL-17 inhibitor (secukinumab, ixekizumab, brodalumab) and 1702 corresponding to an IL-23 inhibitor (guselkumab, risankizumab, tildrakizumab). IL-23 inhibitors had the highest drug survival rates during the entire study period. After 24 months of treatment, the cumulative probabilities of drug survival were 0.92 (95% confidence interval [CI] 0.89-0.95) for risankizumab, 0.90 (95% CI 0.88-0.92) for guselkumab, 0.80 (95% CI 0.76-0.84) for brodalumab, 0.79 (95% CI 0.76-0.82) for ixekizumab, and 0.75 (95% CI 0.73-0.77) for secukinumab. At 36 months, only guselkumab [0.88 (95% CI 0.85-0.91)], ixekizumab [0.73 (95% CI 0.70-0.76)], and secukinumab [0.67 (95% CI 0.65-0.70)] had more than 40 patients at risk of drug discontinuation. Only two drugs had more than 40 patients at risk of drug discontinuation at 48 months, with ixekizumab demonstrating to have a higher cumulative probability of drug survival [0.71 (95% CI 0.68-0.75)] when compared with secukinumab [0.63 (95% CI 0.60-0.66)]. Secondary failure was the main cause for drug discontinuation. According to the final multivariable model, patients receiving risankizumab, guselkumab, and ixekizumab were significantly less likely to discontinue treatment than those receiving secukinumab. Previous exposure to biologic agents, absent family history of psoriasis, higher baseline body mass index (BMI), and higher baseline Psoriasis Area and Severity Index (PASI) were identified as predictors of drug discontinuation. Conclusion: The cumulative probability of drug survival of both IL-17 and IL-23 inhibitors was higher than 75% at 24 months, with risankizumab and guselkumab demonstrating to have overall cumulative probabilities ≥ 90%. Biological agent chosen, prior exposure to biologic agents, higher baseline BMI and PASI values, and absence of family history of psoriasis were identified as predictors for drug discontinuation. Risankizumab, guselkumab, and ixekizumab were less likely to be discontinued than secukinumab